Researchers reported in the online issue of Nature Medicine that a popular diabetes drug, marketed as Avandia, might cause an increase in bone thinning. The research suggests that treating type 2 diabetes on a long-term basis with rosiglitazone, as Avandia is called, could lead to osteoporosis.

The body is constantly breaking down and rebuilding bones. The researchers found in mice, that the drug caused an increased activity of the cells that cause bones to break down. This bone removal activity may account for the increased risk of fractures found in women with type 2 diabetes who take the drug.
Read the rest of this entry »

Avandia, diabetes drugs, diabetes treatment, rosiglitazone, type 2 diabetes

If you’re new here, you may want to subscribe to my RSS feed. Thanks for visiting!